Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...
A company spokesperson said the ad was a "direct response" the Hims & Hers Super Bowl commercial. The ad features a vial that reads "compounded semaglutide" and a syringe. "Some compounded ...
Before Hims & Hers' commercial even aired, Democratic Sen. Dick Durbin of Illinois and Republican Sen. Roger Marshall of Kansas sent a letter to the FDA asking the agency to take action for what ...
Compounded weight-loss medications, such as those promoted in the Hims & Hers Super Bowl commercial “Sick of the System,” aren’t approved by the FDA. © 2025 ...
Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 ...
23d
MarketBeat on MSNHims & Hers: From Viral Ad to Volatile StockDetailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.
HIMS), a telehealth platform, has risen a stellar 43% in a week. Much of this move came after the company’s controversial Super Bowl commercial generated widespread attention following Sunday ...
Hims & Hers saw a massive YTD surge, but FDA news led to a pullback. Find out why HIMS stock is still undervalued and why ...
BofA analyst Allen Lutz notes that the Food and Drug Administration yesterday provided updated enforcement timelines for semaglutide and ...
Hims & Hers Health shares were headed for their biggest single-day plunge as Wall Street analysts questioned the telehealth provider's lofty sales forecast on Tuesday amid looming restrictions on ...
“The recent explosion in irresponsible and misleading advertising about compounded GLP-1 (glucagon-like peptide-1) drugs, like the Hims & Hers Super Bowl commercial, puts patients’ safety at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results